Frontiers in Cardiovascular Medicine

FEBRUARY 5, 2024

Despite developments in circulating biomarker and imaging technology in the assessment of cardiovascular disease, the surveillance and diagnosis of heart transplant rejection has continued to rely on histopathologic interpretation of the endomyocardial biopsy.

Heart Transplant 64

Heart Transplant Transplant Biomarkers Technology 64

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4139383-A4139383, November 12, 2024. Background:Immunosuppressive (IS) therapy is currently used as first-line treatment for heart transplant (HTx) rejection. However, they are not without complications, and less toxic therapies are needed.

Heart Transplant 40

Heart Transplant Transplant Cardiovascular Disease Outcomes 40

DAIC

APRIL 30, 2024

Cardiovascular diseases are still among the top causes of death worldwide, and especially prevalent in developed countries. Myocardial infarctions , commonly known as “heart attacks,” are on the rise, resulting in a significant number of deaths each year.

Transplant 105

Transplant Heart Transplant Myocardial Infarction Heart attacks 105

Cardiology Update

APRIL 9, 2024

Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). The Impella CP is a catheter-based, axial flow pump that pumps blood directly from the left ventricle into the circulation. It is able to deliver 3.5L/min

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52

Dr. Paddy Barrett

MAY 31, 2024

The prevalence of smoking back in the 1950s would have been much higher, but even recent studies on ‘healthy’ heart transplant donors who died from events such as road traffic accidents still show high rates of very early-stage plaque buildup 4. It is a marker of where someone is on a disease progression pathway.

Heart Disease 97

Heart Disease Plaque Heart attacks Heart Attack 97